Longevity & Aging Population
Populations across most developed markets are ageing, which steadily raises demand for care, mobility, and treatment of age related disease. It is one of the few themes whose demand is already fixed by demographics.
60 stocks
| Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|
51
LENSAR
LNSR
$74.1M
| – | – | – | – |
|
52
National Healthcare Properties
NHP
$1.1B
| – | – | – | – |
|
53
PACS Group
PACS
$7.56B
| – | – | – | – |
|
54
P3 Health Partners
PIII
$16.2M
| – | – | – | – |
|
55
RxSight
RXST
$194M
| – | – | – | – |
|
56
Strawberry Fields REIT
STRW
$183M
| – | – | – | – |
|
57
Telomir Pharmaceuticals
TELO
$77.3M
| – | – | – | – |
|
58
Universe Pharmaceuticals Inc
UPC
$20.9M
| – | – | – | – |
|
59
Corgi Longevity Consumer ETF
YUNG
$967K
| – | – | – | – |
|
60
Jin Medical International
ZJYL
$158M
| – | – | – | – |
|